FindTrial
Sign In

Application effect of etomidate combined with oxycodone in painless gastroscopy in patients with liver cirrhosis

Application effect of etomidate combined with oxycodone in painless gastroscopy in patients with liver cirrhosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057571
Enrollment
Unknown
Registered
2022-03-15
Start date
2022-03-09
Completion date
Unknown
Last updated
2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General surgery

Interventions

Group A:Propofol
Group B:Etomidate

Sponsors

Beijing You'an Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Aged from 18 to 85 years old; 2. BMI 18~25kg/m2; 3. Liver function child-pugh A or/and B; 4. Esophagealvarices grade G3; 5. Volunteer signed consent.

Exclusion criteria

Exclusion criteria: 1. Opioid drug allergy, use of monoamine oxidase inhibitor for a long time, severe hepatic and kidney disease, coagulopathy, bronchial asthma, chronic obstructive pulmonary diseases, pulmonary heart disease, intracranial hypertension, and inability to comprehend study-related procedures.

Design outcomes

Primary

MeasureTime frame
Respiratory depression;—

Countries

China

Contacts

Public ContactQuan Zhefeng

Beijing You'an Hospital, Capital Medical University

15811190059@126.com+86 15811190059

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026